Ching Sung Hsu
Chairman at Formosa Lithium Iron Oxide Corp.
Profile
Ching Sung Hsu is currently the Chairman at Formosa Lithium Iron Oxide Corp.
Prior to this, he held the position of Vice Chairman at United BioPharma, Inc. and UBI Pharma Inc. He also served as a Director at Changs Ascending Enterprise Co., Ltd.
and Taiwan Leader Biotech Corp.
where he held the position of Director from 2009 to 2017.
Mr. Hsu completed his undergraduate degree from Feng Chia University.
Ching Sung Hsu active positions
| Companies | Position | Start |
|---|---|---|
| Formosa Lithium Iron Oxide Corp. | Chairman | - |
Former positions of Ching Sung Hsu
| Companies | Position | End |
|---|---|---|
| TAIWAN LEADER BIOTECH CORP. | Director/Board Member | 29/03/2017 |
| UBI PHARMA INC. | Director/Board Member | - |
| UNITED BIOPHARMA INC | Director/Board Member | - |
| CHANGS ASCENDING ENTERPRISE CO., LTD. | Director/Board Member | - |
Training of Ching Sung Hsu
| Feng Chia University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| CHANGS ASCENDING ENTERPRISE CO., LTD. | Producer Manufacturing |
| TAIWAN LEADER BIOTECH CORP. | Health Technology |
| UBI PHARMA INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Formosa Lithium Iron Oxide Corp. | |
United BioPharma, Inc.
 United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Ching Sung Hsu
